載入...
Metformin and cancer: Quo vadis et cui bono?
How many lives have already been saved by the anti-cancer drug metformin? Inadvertently perhaps, among the millions of type 2 diabetics with occult or known cancers and who have been prescribed metformin since the 1950s, thousands may have benefited from the anticancer properties of this first-line...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5342329/ https://ncbi.nlm.nih.gov/pubmed/27356748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10262 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|